Stem Cell therapy is one form of Comprehensive Prolotherapy available for arthritis treatment, sports injury rehab, and chronic pain relief at Caring Medical and Rehabilitation Services.
Read more:
Bone Marrow Aspiration - Stem Cell Therapy
In 2006 scientists learned how to create a pluripotent stem cell out of a human skin cell. These cells, called induced pluripotent stem (iPS) cells have many of the characteristics of embryonic stem cells including the ability to create mature cell types
See the rest here:
Jerome Zack: Creating iPS Cells
Huntington's disease is an inherited neurodegenerative disorder that typically strikes in a person's thirties and leads to death about 10 to 15 years later. No effective therapy exists for the disease. Jan Nolta, director of the UC Davis Stem Cell Program and Institute for Regenerative Cures, has a CIRM Early Translational Award to develop stem cell-based therapies for Huntington's disease.
Read more here:
Stem Cell Research: Huntington's Disease
Aarff.com does a followup on Duffy, a 10 year old Lab who underwent stem cell therapy two months ago in June 2011
Go here to see the original:
Duffy Update, Post Stem Cell Therapy
(HealthDay News) -- A major analysis of data on potential triggers for heart attacks finds that many of the substances and activities Americans indulge in every day -- coffee, alcohol, sex, even breathing -- can all help spur an attack.
Because so many people are exposed to dirty air, air pollution while stuck in traffic topped the list of potential heart attack triggers, with the researchers pegging 7.4 percent of heart attacks to roadway smog.
But coffee was also linked to 5 percent of attacks, booze to another 5 percent, and pot smoking to just under 1 percent, the European researchers found.
Among everyday activities, exerting yourself physically was linked to 6.2 percent of heart attacks, indulging in a heavy meal was estimated to trigger 2.7 percent, and sex was linked to 2.2 percent.
The researchers stressed that the risk for heart attack from any one of these factors to a particular person at any given time is extremely small. But spread out over the population, they can add up.
For example, air pollution is a minor trigger for heart attacks, but since so many people are exposed to smog, it triggers many more heart attacks than other more potent triggers, such as alcohol and cocaine. Read more...
(HealthDay News) -- A major analysis of data on potential triggers for heart attacks finds that many of the substances and activities Americans indulge in every day -- coffee, alcohol, sex, even breathing -- can all help spur an attack.
Because so many people are exposed to dirty air, air pollution while stuck in traffic topped the list of potential heart attack triggers, with the researchers pegging 7.4 percent of heart attacks to roadway smog.
But coffee was also linked to 5 percent of attacks, booze to another 5 percent, and pot smoking to just under 1 percent, the European researchers found.
Among everyday activities, exerting yourself physically was linked to 6.2 percent of heart attacks, indulging in a heavy meal was estimated to trigger 2.7 percent, and sex was linked to 2.2 percent.
The researchers stressed that the risk for heart attack from any one of these factors to a particular person at any given time is extremely small. But spread out over the population, they can add up.
For example, air pollution is a minor trigger for heart attacks, but since so many people are exposed to smog, it triggers many more heart attacks than other more potent triggers, such as alcohol and cocaine. Read more...
Franklin is a patient with spinal cord injury.
Continued here:
Spinal Cord Injury - Stem Cell Therapy
Since 2002, ESC therapy has treated over 10000 patients with degenerative diseases, injury and cancer, now it has move on to help people to delay ageing as disease usually comes from weaken and aged cells.
Original post:
Embryonic stem cell therapy in China (www.esctherapy.com)
Dr. Damon Noto at Spine and Joint Center in New Jersey offers cutting-edge, non-invasive regenerative medicine including stem cell treatment and PRP to treat patients with spinal and joint problems.
See more here:
Stem Cell Therapy (Regenerative Medicine) in New Jersey
Medical breakthrough shows the promise of stem cell medicine.
See more here:
Doctors Use Stem Cells to Grow New Windpipes
Each day the media presents horrific news of death and destruction caused by war, terrorism, and other violence. It virtually ignores a silent but much more deadly enemy . . . heart disease.
More than 1.5 million people will have a heart attack this year, with 1 million deaths resulting from heart attacks (or a death every 30 seconds). When it comes to combating heart disease, most information sources promote drugs and surgery as the only viable defenses. We need to keep in mind that angioplasty and bypass surgery have some significant adverse outcomes, including heart attacks, stroke and death. Most people treated with such interventions continue to suffer from, and eventually die from, heart disease. The average person is not aware that there are safer, more effective options available. Read more...
Cardiofy Heart Care Supplement
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
International Stem Cell Corporation (OTCBB: ISCO) announced today that Kenneth Aldrich, Chairman, will be presenting at the 2011 Southern California Investor Conference on Monday, August 29, 2011 at 1:30 p.m. Pacific (4:30 p.m. Eastern). The conference takes place at The Island Hotel in Newport Beach, California.
The Southern California Investor Conference is the only conference focused exclusively on the wealth of exciting growth companies from Southern California. The annual one-day conference features more than 35 companies from the region presenting to attendees from throughout the nation. The conference is open to the public and investors can find a list of 2011 presenting companies and registration information at http://www.CaliforniaStocks.com
A webcast of the International Stem Cell Corporation presentation will be accessible online at http://events.powerstream.net/002/00271/20110829_SCIC_T2/ or from the link on the Company's web site at http://www.internationalstemcell.com. An archived version will be available for 30 days.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com
or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100
dmarkley@lhai.com
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
Each day the media presents horrific news of death and destruction caused by war, terrorism, and other violence. It virtually ignores a silent but much more deadly enemy . . . heart disease.
More than 1.5 million people will have a heart attack this year, with 1 million deaths resulting from heart attacks (or a death every 30 seconds). When it comes to combating heart disease, most information sources promote drugs and surgery as the only viable defenses. We need to keep in mind that angioplasty and bypass surgery have some significant adverse outcomes, including heart attacks, stroke and death. Most people treated with such interventions continue to suffer from, and eventually die from, heart disease. The average person is not aware that there are safer, more effective options available. Read more...
Cardiofy Heart Care Supplement
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
International Stem Cell Corporation (OTCBB: ISCO) announced today that Kenneth Aldrich, Chairman, will be presenting at the 2011 Southern California Investor Conference on Monday, August 29, 2011 at 1:30 p.m. Pacific (4:30 p.m. Eastern). The conference takes place at The Island Hotel in Newport Beach, California.
The Southern California Investor Conference is the only conference focused exclusively on the wealth of exciting growth companies from Southern California. The annual one-day conference features more than 35 companies from the region presenting to attendees from throughout the nation. The conference is open to the public and investors can find a list of 2011 presenting companies and registration information at http://www.CaliforniaStocks.com
A webcast of the International Stem Cell Corporation presentation will be accessible online at http://events.powerstream.net/002/00271/20110829_SCIC_T2/ or from the link on the Company's web site at http://www.internationalstemcell.com. An archived version will be available for 30 days.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation into hundreds of millions of individuals of differing genders, ages and racial background. This offers the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
International Stem Cell Corporation
Kenneth C Aldrich, Chairman
760-940-6383
kaldrich@intlstemcell.com
or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100
dmarkley@lhai.com
Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss
Franklin is a patient with spinal cord injury. This video is the experience of Franklin R. who underwent stem cell treatment to improve his condition after an accident that left him paraplegic.
Read the original here:
Spinal Cord Injury - Stem Cell Therapy
Medicenter, a Stem Cells clinic in Guatemala, Central America. Mr. Gemperline had a stem cell transplantation
More here:
Stem cell therapy in Guatemala - (closer than China)